News - Cardio-vascular, Diovan

Filter

Current filters:

Cardio-vascularDiovan

Popular Filters

Japan to investigate Novartis promotion of Diovan; US allegation over Exjade

Japan to investigate Novartis promotion of Diovan; US allegation over Exjade

10-01-2014

Swiss drug major Novartis faced two problems yesterday, when the Japanese Ministry of Health Labor and…

Asia-PacificCardio-vascularDiovanExjadeHematologyLegalMarkets & MarketingNorth AmericaNovartisPharmaceuticalUSA

Japanese lawmakers are stepping in to Diovan investigation

07-10-2013

Members of Japan’s Diet (Congressmen) have formed a bipartisan study group to examine Swiss drug major…

Asia-PacificCardio-vascularDiovanNovartisPharmaceuticalPoliticsRegulationResearch

Novartis' research study questioned in Japan

15-07-2013

Swiss drug major Novartis (NOVN: VX) has admitted that there was an undisclosed conflict of interest…

Asia-PacificCardio-vascularDiovanNovartisPharmaceuticalResearch

Forest Lab's nebivolol and valsartan combo performs well in Ph III hypertension trial

28-06-2013

US drugmaker Forest Laboratories (NYSE:FRX) has announced positive top-line results from an eight-week…

BystolicCardio-vascularDiovanForest LaboratoriesnebivololPharmaceuticalResearchvalsartan

Takeda's Edarbi set to be gold standard for hypertension

06-03-2012

Based on clinical data and the opinions of interviewed thought leaders, Edarbi (azilsartan medoxomil),…

Cardio-vascularDiovanEdarbiGlobalMarkets & MarketingNovartisPharmaceuticalTakeda Pharmaceuticals

Actavis debuts generic Diovan in major European markets

20-11-2011

Iceland-headquartered generic drug major Actavis Group revealed on Friday that it has launched Valsartan…

ActavisCardio-vascularDiovanDiovan HCTEuropeGenericsMarkets & MarketingNovartisvalsartan

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top